Benjamin F. Edwards & Company’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Benjamin F. Edwards & Company’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-10,000	Closed	-$9K	–	1941
2022 Q4	$9K	Hold	10,000	–	–	﹤0.01%	1463
2022 Q3	$16K	Hold	10,000	–	–	﹤0.01%	1309
2022 Q2	$20K	Hold	10,000	–	–	﹤0.01%	1249
2022 Q1	$23K	Hold	10,000	–	–	﹤0.01%	1209
2021 Q4	$47K	Hold	10,000	–	–	﹤0.01%	1069
2021 Q3	$76K	Hold	10,000	–	–	﹤0.01%	922
2021 Q2	$97K	Sell	10,000 -10,000	-50%	-$79.6K	﹤0.01%	854
2021 Q1	$165K	Buy	+20,000	New	+$211K	0.01%	721
2020 Q3	–	Sell	-400	Closed	-$3K	–	1794
2020 Q2	$3K	Buy	+400	New	+$1.53K	﹤0.01%	1554

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return